OTOVEL is a Auricular (otic) For Solution in the Human Prescription Drug category. It is labeled and distributed by Arbor Pharmaceuticals. The primary component is Ciprofloxacin; Fluocinolone Acetonide; Polysorbate 80.
Product ID | 24338-080_736bbfd0-1fbd-4615-80f6-3f5f1ae12284 |
NDC | 24338-080 |
Product Type | Human Prescription Drug |
Proprietary Name | OTOVEL |
Generic Name | (ciprofloxacin And Fluocinolone Acetonide) |
Dosage Form | For Solution |
Route of Administration | AURICULAR (OTIC) |
Marketing Start Date | 2016-04-29 |
Marketing Category | NDA / NDA |
Application Number | NDA208251 |
Labeler Name | Arbor Pharmaceuticals |
Substance Name | CIPROFLOXACIN; FLUOCINOLONE ACETONIDE; POLYSORBATE 80 |
Active Ingredient Strength | 873 ug/.25mL; ug/.25mL; ug/.25mL |
Pharm Classes | Quinolone Antimicrobial [EPC],Quinolones [CS],Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA] |
NDC Exclude Flag | N |
Listing Certified Through | 2019-12-31 |
Marketing Start Date | 2016-04-29 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA208251 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2016-04-29 |
Marketing End Date | 2019-10-17 |
Marketing Category | NDA |
Application Number | NDA208251 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2016-04-29 |
Marketing Category | NDA |
Application Number | NDA208251 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-10-17 |
Ingredient | Strength |
---|---|
CIPROFLOXACIN | 872.5 ug/.25mL |
SPL SET ID: | 1a7e4806-3138-4b7a-b798-a99e163ee846 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
24338-080 | OTOVEL | (ciprofloxacin and fluocinolone acetonide) |
66992-128 | OTOVEL | ciprofloxacin and fluocinolone acetonide |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
OTOVEL 86875555 5381190 Live/Registered |
LABORATORIOS SALVAT, S.A. 2016-01-14 |